Revelation Biosciences, Inc. (REVB) stock
REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
$3.85−0.03 (-0.77%)
Close on Nov 18, 2026Market cap $15.34MP/E –Yield –
Revelation Biosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Revelation Biosciences
Revelation Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?